Kane Biotech (CVE:KNE) Sets New 52-Week High at $0.14

Kane Biotech Inc (CVE:KNE)’s stock price hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as C$0.14 and last traded at C$0.14, with a volume of 689100 shares trading hands. The stock had previously closed at C$0.13.

The firm has a market capitalization of $10.42 million and a P/E ratio of -3.95. The company has a quick ratio of 0.12, a current ratio of 0.24 and a debt-to-equity ratio of 187.91. The company’s 50 day moving average price is C$0.12.

Kane Biotech (CVE:KNE) last announced its quarterly earnings data on Wednesday, May 22nd. The company reported C($0.01) earnings per share (EPS) for the quarter. The firm had revenue of C$0.62 million during the quarter.

Kane Biotech Company Profile (CVE:KNE)

Kane Biotech Inc, a biotechnology company, researches, develops, and commercializes technologies and products that prevent and remove microbial biofilms worldwide. It develops pet oral care solutions under the StrixNB and bluestem trademarks; animal and human wound care solutions under the DispersinB trademark; medical device coatings under the Aledex trademark; and shampoo for dogs, cats, and horses under the Alosera trademark.

Recommended Story: Earnings Reports

Receive News & Ratings for Kane Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kane Biotech and related companies with MarketBeat.com's FREE daily email newsletter.